Newsletter
April 17, 2024
Anvisa opens its doors to Startups: Stepping towards Innovation in Medicines
Anvisa recently launched a public notice with the aim of selecting Startups involved in the research and development of medicines, in order to provide strategic and regulatory support. This pioneering initiative marks an important moment for the Brazilian innovation scene, as it recognizes the relevance of Startups in the search for more effective and accessible health solutions for the Brazilian population.
As stipulated in the public notice, three Startups will be chosen, one of which is dedicated to the development of herbal medicines, another to new synthetic medicines and the last focused on biological products. The purpose of this selection is to integrate the Startups into the national drug regulatory scenario, providing specific guidance and support for drugs in the early stages of development.
In order to participate in the process, it is necessary for the Startups to be national and duly registered with ANVISA, in addition to demonstrating the potential for prevention or treatment and proving that the candidate drug is in the development phase.
Applications are now open and will remain so until May 7, 2024. The result of the chosen Startups is expected to be announced in June of this year.
For more information on the regulatory and legal developments related to Anvisa’s program to support startups, don’t hesitate to contact our partners: viviane.trojan@kasznarleonardos.com and felipe.monteiro@kasznarleonardos.com.
Last related news
April 22, 2024
New Rules for Payment Transactions by Fixed-Odds Betting Operators in Brazil
In a further step towards regulating the new Betting Law (Law No. 14,790/2023), Normative Ordinance SPA/MF No. 615, of April 16, 2024, … New Rules for Payment Transactions by Fixed-Odds Betting Operators in Brazil
April 17, 2024
Anvisa opens its doors to Startups: Stepping towards Innovation in Medicines
Anvisa recently launched a public notice with the aim of selecting Startups involved in the research and development of medicines, in order … Anvisa opens its doors to Startups: Stepping towards Innovation in Medicines
April 11, 2024
Ministry of Finance Defines Regulatory Agenda for the Betting Market
In another step towards the realization and consolidation of the regulations provided for by the New Betting Law (Law 14.790/2023), the Ministry … Ministry of Finance Defines Regulatory Agenda for the Betting Market